Figure 5.
Effects of sActRIIB therapy on circulating CK levels. The mdx mice treated with the 10.0 mg/kg−1 dose of sActRIIB had a significantly lower concentration of serum CK compared with control mdx mice. ***P < 0.0001.
Effects of sActRIIB therapy on circulating CK levels. The mdx mice treated with the 10.0 mg/kg−1 dose of sActRIIB had a significantly lower concentration of serum CK compared with control mdx mice. ***P < 0.0001.